PFIZER INC (PFE)
Pharmaceutical Preparations
Latest Price
$27.72
TTM P/E
36.47
Normalized P/E
11.56
Div Yield
6.20%
Book Value
14.96
P/B Ratio
1.85
Valuation metrics
adjust assumptions →EPS: $1.36
Book value / share: $15.14
Formula: √(22.5 × EPS × BVPS)
Graham Number
$21.52
22% downside
Norm. op. income: $11.1B (median of 7yr)
Tax rate: 8%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$8.30
70% downside
Base FCF: $9.8B (median of recent 5yr)
Growth: 4%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$18.61
33% downside
EPS: $1.36
Target P/E: 12×
Formula: EPS × P/E
P/E Fair Value
$16.32
41% downside
Institutional Ownership
67.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 529.67M | $12.75B | 9.29% | +31.41M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 372.15M | $8.96B | 6.53% | +2.72M | 2026-06-30 |
| STATE STREET CORP | 307.09M | $7.39B | 5.39% | +5.50M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 135.28M | $3.25B | 2.37% | +1.71M | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 119.24M | $2.87B | 2.09% | +2.50M | 2026-06-30 |
| Fisher Asset Management, LLC | 109.07M | $2.63B | 1.91% | +4.10M | 2026-06-30 |
| MORGAN STANLEY | 96.35M | $2.32B | 1.69% | +3.66M | 2026-06-30 |
| NORGES BANK | 61.51M | $1.48B | 1.08% | -12.03M | 2026-06-30 |
| NORTHERN TRUST CORP | 59.08M | $1.42B | 1.04% | -2.94M | 2026-06-30 |
| Bank of New York Mellon Corp | 57.88M | $1.39B | 1.02% | +4.00M | 2026-06-30 |